<DOC>
	<DOCNO>NCT00829699</DOCNO>
	<brief_summary>The purpose study learn patient diabetes increase heart attack , stroke illness due blood clot cause blockage blood vessel . The propose protocol study separate combine effect high glucose high fat certain cardiovascular response Type 2 DM .</brief_summary>
	<brief_title>Metabolic Causes Thrombosis Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Currently 75-80 % diabetes mellitus ( DM ) patient die due thrombotic cause . Data Centers Disease Control Prevention release 2000 indicated mortality due coronary artery disease decrease except individual diabetes . Clearly disordered metabolism , include abnormal metabolism fat result high triglyceride free fatty acid blood level , occur diabetes predisposes individual increase thrombotic event . Unless underlie mechanism responsible event identify , unprecedented number diabetic patient suffer thrombotic episode next 10 year . The specific aim study determine effect elevate free fatty acid hyperglycemia ( high glucose ) endothelial function thrombolytic balance patient type 2 diabetes , determine effect increase insulin setting .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>Inclusion Criteria 16 Type 2 diabetic patient age 18 60 yr 16 Nondiabetic control age 1860 yr Body mass index &gt; 20 kg/m2 Female volunteer childbearing potential : negative urine pregnancy test Volunteers 40 year old : ECG clinically significant conduction ischemic change . For type 2 diabetes : HBA1C &gt; 5.5 % For type 2 diabetes : Cpeptide &gt; 0.2 nmol , If Cpeptide abnormal clinical suspicion type 1 diabetes , MODY LADA , antiislet cell antiGAD antibody assess establish diagnosis type 2 diabetes vs. type 1/LADA/MODY . PT ( time ) 12.814.6 second , PTT ( time ) 2538 second Exclusion Criteria Any current disease condition alters carbohydrate metabolism ( type 2 DM ) and/or evidence clinically significant cardiac disease Uncontrolled hypertension Pregnancy Subjects unable give voluntary inform consent Subjects history pancreatitis Subjects anticoagulant drug , anemic , know bleeding disease Subjects history GI bleed require treatment Tobacco Use Subjects history heparininduced thrombocytopenia heparin allergy Subjects severe egg legume ( soybean ) allergy Abnormal result follow screen test physical examination clinically significant : Medical history/Physical Exam Exclusion Criteria Fever great 38 degree C screen study initiation Uncontrolled severe hypertension ( i.e. , blood pressure great 160/100 ) Cardiac Abnormalities ( e.g . Heart Failure , Arrhythmia , Cardiomyopathy , ischemic tachycardia , ST segment deviation , etc. , ) history ECG test subject &gt; 40 year old . Diagnosed Pneumonia Hepatic Failure/Jaundice Clinically significant coagulopathy Renal Failure Acute Cerebrovascular/ Neurological deficit Screening Laboratory Tests Exclusion Criteria accord protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>fibrinolytic balance</keyword>
</DOC>